CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Revolution Medicines Inc 's Leverage Ratio

RVMD's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 1.91%, Leverage Ratio fell to 0.04, below the Revolution Medicines Inc 's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2023, 4 other companies have achieved lower Leverage Ratio than Revolution Medicines Inc in the III Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the second quarter 2023 from 63 to 74 .

Explain Leverage Ratio?
Who are RVMD Customers?
What are RVMD´s Total Liabilities?


RVMD Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change 22.9 % 86.6 % 72.82 % 13.71 % 6.77 %
Y / Y Total Liabilities Change -78.82 % -77.58 % -57.26 % -54.01 % 49.31 %
Leverage Ratio MRQ 0.04 0.03 0.06 0.09 0.21
RVMD's Total Ranking # 74 # 63 # 98 # 101 # 562
Seq. Equity Change -10.03 % -2.25 % 38.97 % 0.55 % 36.6 %
Seq. Total Liabilities Change 1.91 % -46.68 % -9.56 % -56.89 % 7.86 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 25
Overall Market # 74


Leverage Ratio Statistics
High Average Low
0.27 0.11 0.02
(Jun 30 2022)   (Sep 30 2020)




Financial Statements
Revolution Medicines Inc 's Equity $ 837 Millions Visit RVMD's Balance sheet
Revolution Medicines Inc 's Total Liabilities $ 31 Millions Visit RVMD's Balance sheet
Source of RVMD's Sales Visit RVMD's Sales by Geography


Cumulative Revolution Medicines Inc 's Leverage Ratio

RVMD's Leverage Ratio for the trailling 12 Months

RVMD Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth 22.9 % 86.6 % 72.82 % 13.71 % 6.77 %
Y / Y Total Liabilities TTM Growth -78.82 % -77.58 % -57.26 % -54.01 % 49.31 %
Leverage Ratio TTM 0.05 0.09 0.14 0.2 0.23
Total Ranking TTM # 2 # 25 # 2 # 217 # 576
Seq. Equity TTM Growth -10.03 % -2.25 % 38.97 % 0.55 % 36.6 %
Seq. Total Liabilities TTM Growth 1.91 % -46.68 % -9.56 % -56.89 % 7.86 %


On the trailing twelve months basis Despite of the net new borrowings of 1.91% during the twelve months period ending in III Quarter 2023 Revolution Medicines Inc has managed to decrease Leverage Ratio in the III Quarter 2023 to 0.05, below Revolution Medicines Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry RVMD recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 2, from total ranking in previous 12 month period at 25.

Explain Leverage Ratio?
Who are RVMD Customers?
What are RVMD´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 0
Healthcare Sector # 1
Within the Market # 2


trailing twelve months Leverage Ratio Statistics
High Average Low
0.23 0.18 0.15
(Sep 30 2022)   (Sep 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity
4d Molecular Therapeutics Inc   0.10 $ 31.679  Millions$ 329.934  Millions
Genenta Science S p a   0.08 $ 1.944  Millions$ 22.884  Millions
Kymera Therapeutics Inc   0.08 $ 32.227  Millions$ 395.535  Millions
Icosavax Inc   0.08 $ 18.916  Millions$ 232.380  Millions
Cabaletta Bio Inc   0.08 $ 12.364  Millions$ 160.923  Millions
Neumora Therapeutics Inc   0.06 $ 32.056  Millions$ 512.693  Millions
Compass Therapeutics Inc   0.06 $ 9.993  Millions$ 160.045  Millions
Avrobio Inc   0.06 $ 5.912  Millions$ 102.858  Millions
Tourmaline Bio Inc   0.06 $ 8.187  Millions$ 142.874  Millions
Intensity Therapeutics Inc   0.06 $ 0.905  Millions$ 15.911  Millions
Cullinan Oncology Inc   0.05 $ 21.897  Millions$ 468.817  Millions
Krystal Biotech Inc   0.05 $ 34.402  Millions$ 755.948  Millions
Revolution Medicines Inc   0.04 $ 30.609  Millions$ 837.458  Millions
Creative Medical Technology Holdings Inc   0.03 $ 0.407  Millions$ 12.092  Millions
Cortexyme Inc   0.03 $ 2.253  Millions$ 83.133  Millions
Vaxcyte Inc   0.03 $ 37.652  Millions$ 1,402.716  Millions
Acumen Pharmaceuticals Inc   0.02 $ 6.098  Millions$ 280.273  Millions

Date modified: 2023-11-07T13:08:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com